News and Reports
-
Curetis IPO priced at EUR 10.00 per Share; raises EUR 40 million
15 November 2015Download -
Allena Pharmaceuticals Announces Presentation of Successful Phase 2 Data from ALLN-177 Program at American Society of Nephrology Kidney Week
12 November 2015Download -
Advanced Accelerator Applications S.A. Announces Pricing of Initial
10 November 2015Download -
Ophthotech Completes Patient Recruitment of the Second Phase 3 Pivotal Trial of Fovista® Anti-PDGF Therapy in Combination with Lucentis® in Wet Age-Related Macular Degeneration
26 October 2015Download -
APR Applied Pharma Research (APR) announces the European Class III CE Mark approval of Nexodyn
16 October 2015Download -
Over 2000 Patients Treated with Ellipse Technologies? MAGEC® System
1 October 2015Download -
AAA Announces Positive Results From Phase 3 Study NETTER-1 Evaluating Lutathera in Patients with Advanced Midgut Neuroendocrine Tumors
27 September 2015Download -
AAA's Lutathera Phase III Meets Primary Endpoint and Data will be Presented in Presidential Session at ECC 2015
16 September 2015Download -
Raptor Pharmaceutical Corp. Expands Rare Disease Portfolio With the Acquisition of Quinsair(TM)
20 August 2015Download -
Allena Pharmaceuticals Initiates Phase 2b Trial of ALLN-177 for Secondary Hyperoxaluria
4 August 2015Download -
Gynesonics raises $43 million in equity financing
22 July 2015Download -
AnaptysBio secures $40 million series D financing
15 July 2015Download -
Celgene to acquire Receptos, advancing leadership in immune-inflammatory diseases
14 July 2015Download -
MEDIAN Technologies announces a private placement of €19.8 Million at a €12 share price
3 July 2015Download -
AAA completes 23 million Euro capital increase with US-based institutions
23 June 2015Download -
Advanced Accelerator Applications reports over 24% growth in sales for the first quarter of 2015
15 June 2015Download -
Eye Diagnostics Innovator i-Optics Closes EUR 13.7 Million Financing Round
22 May 2015Download -
Curetis to Launch Next-Generation Pneumonia Application at ECCMID 2015
16 April 2015Download -
New Clinical Data Show Biological Activity of DLX105 in Patients with Behçet’s Disease
14 April 2015Download -
AAA Reports 29.8% Sales Growth in 2014 and Completes Enrollment in Lutathera Phase III Trial
9 April 2015Download -
Nabriva Therapeutics Announces Financing of up to $120M to Advance Clinical Development of New Class of Antibiotic
7 April 2015Download -
APR Applied Pharma Research s.a. (“APR”) today announced that HBM BioCapital II, a fund advised by HBM Partners Ltd, has acquired a minority stake in APR.
25 March 2015Download -
Allena Pharmaceuticals Announces Positive Phase 2a Data of ALLN-177 for the Treatment of Hyperoxaluria
18 March 2015Download -
Curetis Closes EUR 14.5 Million Extension of Series B Financing
24 November 2014Download -
AAA Reports Over 25% Growth in Sales for the First Nine Months of 2014
20 November 2014Download